Prolonged survival in postoperative recurrent EGFR-L858R NSCLC: A 24-year case report

Prolonged survival in postoperative recurrent EGFR-L858R NSCLC: A 24-year case report

The use of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) is well-established for the treatment of advanced non-small cell lung cancer (NSCLC) patients with activating EGFR mutations. In this study, we report the long-term efficacy of EGFR-TKI therapy in a patient with posto...

Full description

Saved in:
Bibliographic Details
Main Authors: Yoshihiro Go, Chinatsu Yoshizaki, Yuki Yoshida, Shiho Nohmi, Rui Kusakado, Yuichiro Saito, Kensuke Izumizaki, Takafumi Ogawa, Takashi Suzuki, Fumihiro Yamaguchi
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Current Problems in Cancer: Case Reports
Subjects:
Epidermal growth factor receptor-tyrosine kinase inhibitor
Non-small cell lung cancer
EGFR L858R mutation
Long-term survival
Postoperative recurrence
Online Access:http://www.sciencedirect.com/science/article/pii/S2666621924000516
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666621924000516

Similar Items